Altimmune, Inc. (ALT)
3.50
-0.10
(-2.78%)
USD |
NASDAQ |
Mar 13, 16:00
3.505
0.00 (0.00%)
After-Hours: 20:00
Altimmune Total Liabilities (Quarterly) : 55.04M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.94B |
| CorMedix, Inc. | 472.32M |
| Amgen, Inc. | 81.93B |
| Viking Therapeutics, Inc. | 76.67M |
| Verastem, Inc. | 189.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 279.93M |
| Shareholders Equity (Quarterly) | 224.89M |
| Debt to Equity Ratio | 0.1587 |
| Current Ratio | 18.54 |
| Net Debt Paydown Yield | -1.69% |